Pain Information Center

Neurology Information Center

Smartphone Use and Headache: What’s the Link?

By

Madeline Morr

Publish Date March 30, 2020

Researchers conducted a cross-sectional, hospital-based study to determine the association between smartphone use and worsening symptoms of migraine, chronic migraine, and tension-type headaches.

Neurology Information Center

People With Migraine Often Present With Metacognitive Dysfunctions

By

Brandon May

Publish Date March 26, 2020

Compared with people without migraine, people with migraine and migraine with medication overuse headache often have deficits in metacognition.

Neurology Information Center

Intranasal Ketamine Reduces Pain in Children Hospitalized for Migraine

By

Brandon May

Publish Date March 25, 2020

A single-center study showed that intranasal ketamine effectively reduced pain in children with migraine from hospital admission to discharge.

Neurology Information Center

Drug Therapies Evaluated for Pediatric Migraine Prophylaxis

By

Cassandra Pardini, PharmD

Publish Date March 24, 2020

There is limited evidence supporting the prophylactic use of pharmacological therapies for the prevention of migraine in pediatric patients, according to the findings of a recently published systematic review and network meta-analysis.

Pain Information Center

Author Conflicts of Interest May Influence Cannabidiol Conclusions

Publish Date March 18, 2020

Supportive conclusions seen in more studies with vs without CBD-related industry funding.

Neurology Information Center

Fatigue, Anemia, Pain, Sleep Disorders Found to Be Part of MS Prodrome

By

Clinical Advisor Contributing Writer

Publish Date March 5, 2020

Fatigue, anemia, pain, and sleep disorders form part of the prodrome in MS.

Pain Information Center

FDA Approves OTC Combination of Ibuprofen and Acetaminophen

By

Steve Duffy

Publish Date March 5, 2020

Each caplet contains 125mg of Ibuprofen, a nonsteroidal anti-inflammatory drug (NSAID) and 250mg of acetaminophen and is indicated for adults and children 12 years of age and older.

Practice Management Information Center

2019 Pedestrian Fatalities Hit 30-Year Record High

Publish Date March 4, 2020

More pedestrian crashes happening at night, with trucks, and with distracted drivers.

Obesity Information Center

The Impact of Weight Loss on Migraine Characteristics in Patients With Obesity

By

Amit Akirov, MD

Publish Date February 28, 2020

Among patients with obesity and migraine, weight loss is associated with reduction of migraine frequency, pain severity, and attack duration and disability.

Pain Information Center

Vitamin D Status May Affect Spinal Degenerative Disease, Back Pain in Older Women

By

Amit Akirov, MD

Publish Date February 28, 2020

Severe vitamin D deficiency was linked to lumbar degenerative disease and low back pain in postmenopausal women.

Pain Information Center

2002 to 2018 Saw Increases in Heroin Use, Use Disorder, Injection

Publish Date February 17, 2020

800,000 US adults surveyed; prevalence of heroin use increased from 0.17 to 0.32%.

Neurology Information Center

Can Functional MRI Aid in the Diagnosis of Migraine?

By

Amit Akirov, MD

Publish Date February 17, 2020

Distinct pattern of abnormal brain connection on fMRI can assist in the differentiation between a healthy brain and a brain with migraine without aura.

Pain Management Information Center

Nonpharmaceutical Interventions Aid Low Back Pain

Publish Date February 14, 2020

Movement-based mind-body interventions could be effective alternatives to drugs, surgery, injections.

Pediatrics Information Center

Prophylactic Migraine Treatment Has No Effect in Children

Publish Date February 13, 2020

Findings based on review of 23 studies with variety of treatments compared with placebo.

Pain Information Center

Kratom Seems Safe for Pain, Anxiety, Opioid Withdrawal

Publish Date February 10, 2020

Kratom most commonly used daily; few serious adverse events self-reported among users.

Neurology Information Center

Ubrogepant Works Quickly to Relieve Acute Migraine Pain

By

Rita Aghjayan

Publish Date January 31, 2020

Ubrogepant, the newly approved calcitonin gene-related peptide antagonist, can relieve migraine symptoms within 2 hours after initial dose.

Neurology Information Center

Merging Chronic Migraine and High-Frequency Episodic Migraine Definitions Potentially Harmful for Patients

By

Brandon May

Publish Date January 29, 2020

Researchers argue that chronic migraine should not be solely defined by headache frequency alone.

Sleep Information Center

New Findings on Timing of Migraines After Poor Sleep

By

Madeline Morr

Publish Date January 9, 2020

Researchers found that a poor night’s sleep may increase risk for migraine the following day, rather than the next morning.

Pain Information Center

Overdose, Relapse After Buprenorphine Discontinuation High

Publish Date January 1, 2020

The longer patients continue with buprenorphine treatment, the lower their risk of adverse outcomes.

Pain Information Center

Evidence Supports Use of High-Dose Aspirin for Migraine

Publish Date December 17, 2019

High-dose aspirin safe, effective for acute migraine; low-dose aspirin can prevent recurrent attacks.